These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
58 related articles for article (PubMed ID: 1836139)
1. Erythropoietin rapidly reduces phosphorylation of a membrane protein in a murine erythroleukemia cell line. Sawada T; Tsuda H; Mori KJ; Kawakita M; Takatsuki K Int J Hematol; 1991 Apr; 54(2):109-15. PubMed ID: 1836139 [TBL] [Abstract][Full Text] [Related]
3. Erythropoietin-induced erythroid differentiation of the human erythroleukemia cell line TF-1 correlates with impaired STAT5 activation. Chrétien S; Varlet P; Verdier F; Gobert S; Cartron JP; Gisselbrecht S; Mayeux P; Lacombe C EMBO J; 1996 Aug; 15(16):4174-81. PubMed ID: 8861946 [TBL] [Abstract][Full Text] [Related]
4. Rapid protein tyrosine phosphorylation selectively induced in murine responsive ELM-I-1 cells by erythropoietin. Sawada T; Tsuda H; Kawakita M; Takatsuki K Exp Hematol; 1992 Jun; 20(5):629-32. PubMed ID: 1587309 [TBL] [Abstract][Full Text] [Related]
5. The erythropoietin-sensitive membrane phosphoprotein, pp43, is a protein serine/threonine kinase. Lunn ED; Sytkowski AJ Arch Biochem Biophys; 1997 Jun; 342(2):344-50. PubMed ID: 9186497 [TBL] [Abstract][Full Text] [Related]
6. Physician Education: The Erythropoietin Receptor and Signal Transduction. Yoshimura A; Arai K Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012 [TBL] [Abstract][Full Text] [Related]
7. Alteration of nuclear proto-oncogene expression by erythropoietin (Epo) in Epo-responsive murine cell lines. Tsuda H; Aso N; Sawada T; Hata H; Kawakita M; Mori KJ; Takatsuki K Int J Cell Cloning; 1991 Mar; 9(2):123-33. PubMed ID: 2037810 [TBL] [Abstract][Full Text] [Related]
8. Erythropoietin increases the radioresistance of a clonal hematopoietic progenitor cell line expressing a transgene for the erythropoietin receptor. Santucci MA; Pierce JH; Zannini S; Fortuna A; Frezza G; Babini L; Rosenstein MM; Greenberger JS Stem Cells; 1994 Sep; 12(5):506-13. PubMed ID: 7804124 [TBL] [Abstract][Full Text] [Related]
9. Alteration of phosphotyrosine-containing proteins during differentiation of chicken erythroleukemia cells (HD3). Grdisa M Cell Biochem Funct; 1998 Dec; 16(4):277-82. PubMed ID: 9857490 [TBL] [Abstract][Full Text] [Related]
10. Erythropoietin fails to interfere with the antiproliferative and cytotoxic effects of antitumor drugs. Gewirtz DA; Di X; Walker TD; Sawyer ST Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2232-8. PubMed ID: 16609039 [TBL] [Abstract][Full Text] [Related]
11. Erythroid potentiating activity of tissue inhibitor of metalloproteinases on the differentiation of erythropoietin-responsive mouse erythroleukemia cell line, ELM-I-1-3, is closely related to its cell growth potentiating activity. Murate T; Yamashita K; Ohashi H; Kagami Y; Tsushita K; Kinoshita T; Hotta T; Saito H; Yoshida S; Mori KJ Exp Hematol; 1993 Jan; 21(1):169-76. PubMed ID: 8417953 [TBL] [Abstract][Full Text] [Related]
12. Erythropoietin rapidly alters phosphorylation of pp43, an erythroid membrane protein. Choi HS; Wojchowski DM; Sytkowski AJ J Biol Chem; 1987 Mar; 262(7):2933-6. PubMed ID: 3469202 [TBL] [Abstract][Full Text] [Related]
13. Proliferation and differentiation of erythroleukemia cell line (ELM-I-1) in response to erythropoietin and interleukin 3. Shiozaki M; Itoh K; Mori KJ Leuk Res; 1990; 14(3):287-91. PubMed ID: 2319808 [TBL] [Abstract][Full Text] [Related]
14. Expression and activation of B-Raf kinase isoforms in human and murine leukemia cell lines. Eychène A; Dusanter-Fourt I; Barnier JV; Papin C; Charon M; Gisselbrecht S; Calothy G Oncogene; 1995 Mar; 10(6):1159-65. PubMed ID: 7535416 [TBL] [Abstract][Full Text] [Related]
15. Shedding of tyrosine and serine/threonine ecto-protein kinases from human leukemic cells. Paas Y; Fishelson Z Arch Biochem Biophys; 1995 Feb; 316(2):780-8. PubMed ID: 7864634 [TBL] [Abstract][Full Text] [Related]
16. Antisense src expression inhibits proliferation and erythropoietin-induced erythroid differentiation of K562 human leukemia cells. Kitanaka A; Waki M; Kamano H; Tanaka T; Kubota Y; Ohnishi H; Takahara J; Irino S Biochem Biophys Res Commun; 1994 Jun; 201(3):1534-40. PubMed ID: 7517673 [TBL] [Abstract][Full Text] [Related]
17. Erythropoietin induces tyrosine phosphorylation and kinase activity of the c-fps/fes proto-oncogene product in human erythropoietin-responsive cells. Hanazono Y; Chiba S; Sasaki K; Mano H; Yazaki Y; Hirai H Blood; 1993 Jun; 81(12):3193-6. PubMed ID: 7685196 [TBL] [Abstract][Full Text] [Related]
18. Both stroma and stem cell factor maintain long-term growth of ELM erythroleukemia cells, but only stroma prevents erythroid differentiation in response to erythropoietin and interleukin-3. O'Prey J; Leslie N; Itoh K; Ostertag W; Bartholomew C; Harrison PR Blood; 1998 Mar; 91(5):1548-55. PubMed ID: 9473219 [TBL] [Abstract][Full Text] [Related]
19. A rapid fatal erythroleukemia caused by J2E cells can be treated ex vivo with erythropoietin. Farr TJ; Lai CM; Beilharz MW; Papadimitriou J; Riches K; Rossi E; Garcia-Webb P; Klinken SP Leukemia; 1995 May; 9(5):900-7. PubMed ID: 7769854 [TBL] [Abstract][Full Text] [Related]
20. The functional form of the erythropoietin receptor is a 78-kDa protein: correlation with cell surface expression, endocytosis, and phosphorylation. Sawyer ST; Hankins WD Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6849-53. PubMed ID: 8341708 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]